U.S. patent number D931,370 [Application Number D/722,202] was granted by the patent office on 2021-09-21 for label for a vial. This patent grant is currently assigned to Genentech, Inc.. The grantee listed for this patent is Genentech, Inc.. Invention is credited to Erin Susan Araj, Mahesh Khurana, Dominique Daniel Schall, Kai Zheng.
United States Patent | D931,370 |
Khurana , et al. | September 21, 2021 |
Inventors: | Khurana; Mahesh (San Bruno, CA), Schall; Dominique Daniel (Lorrach, DE), Zheng; Kai (Foster City, CA), Araj; Erin Susan (Pleasanton, CA) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Applicant: |
|
||||||||||
Assignee: | Genentech, Inc. (South San
Francisco, CA) |
||||||||||
Appl. No.: | D/722,202 | ||||||||||
Filed: | January 27, 2020 |
Current U.S. Class: | D20/22; D20/27 |
Current International Class: | 1908 |
Field of Search: | ;D7/387,624.2 ;D9/434,550,563 ;D10/46,47,52,104.1,104.2 ;D14/490,491 ;D19/1-12 ;D20/10,11,18,22-29,42,49 |
1987418 | January 1935 | Plishker |
3212214 | October 1965 | Patterson |
3273781 | September 1966 | Mills |
4048737 | September 1977 | McDermott |
D275177 | August 1984 | Villanueva |
5135125 | August 1992 | Andel et al. |
5490658 | February 1996 | Coward et al. |
5732491 | March 1998 | Burtch |
5823503 | October 1998 | Wasserman |
6110553 | August 2000 | Grosskopf et al. |
D443894 | June 2001 | Schwartz |
6546656 | April 2003 | Twentier |
D596240 | July 2009 | Muniz |
D613451 | April 2010 | Welsh |
D676490 | February 2013 | Bratter |
D676572 | February 2013 | Tarriff |
D702765 | April 2014 | Williams |
D729313 | May 2015 | Glass |
D741955 | October 2015 | Clark |
D752682 | March 2016 | Sato |
D785710 | May 2017 | Lin |
D785711 | May 2017 | Lin |
D786976 | May 2017 | Keating |
D860322 | September 2019 | Edwards |
D888828 | June 2020 | Dittrich |
D892212 | August 2020 | Sato |
2002/0073587 | June 2002 | Twentier |
2004/0104274 | June 2004 | Kotik |
2007/0014958 | January 2007 | Chaplin et al. |
102004046552 | Apr 2006 | DE | |||
102012015557 | Feb 2014 | DE | |||
2695824 | Feb 2014 | EP | |||
D129022 | Jun 2009 | TW | |||
D140218 | Apr 2011 | TW | |||
Albumin (Human) 25% Solution AlbuRx .RTM.25, CSL Behring, located at <http://www.fffenterprises.com/assets/downloads/pi-Albumin-PPF_ALBURX%- 2025_CSL%20Behring.pdf> last visited Jan. 7, 2021, 2 pages. cited by applicant . Alburx 25% 100ml CSL, prescribing details, located at <https://biosupply.fffenterprises.com/alburx-25-100ml-esl-5.html#> last visited Jan. 7, 2021, 3 pages. cited by applicant . Goldberg, C. (Dec. 18, 2017). "Mass General Hospital Raises Red Flag About National Shortage of IV Fluids," CommonHealth, located at <https://www.wbur.org/commonhealth/2017/12/18/mass-general-hospital-iv- -fluids> last visited Jan. 7, 2021, 7 pages. cited by applicant . NDC 44206-310 Alburx, Albumin (human) description, located at <https://ndclist.com/ndc/44206-310#description> last visited Jan. 7, 2021, 7 pages. cited by applicant. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.